Stephen F. Mahoney serves as Executive at Kiniksa Pharmaceuticals, Ltd., where they oversee executive responsibilities. Since joining the company, Stephen F. Mahoney has executed 5 insider transactions totaling $537.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 27, 2024 involved purchasing 21,400 shares valued at $499.3K.
Stephen F. Mahoney currently holds 21,400 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen F. Mahoney has been a net buyer of KNSA stock. They have purchased $499.3K and sold $38.6K worth of shares.
Stephen F. Mahoney's most recent insider trade was on Sep 27, 2024, when they purchased 21,400 shares at $23.33 per share.
Get notified when new Form 4 filings are submitted
| $0.94 |
| Discretionary |
| Sep 16, 2021 | MGTA | $38.6K | Sale | 5,736 | $6.73 | Discretionary |
| Sep 14, 2021 | MGTA | $0 | Award | 20,000 | $N/A | Discretionary |
| May 29, 2018 | KNSA | $0 | Conversion | 6,392 | $N/A | Discretionary |